CHAPTER 1:INTRODUCTION
1.1.Research methodology
1.1.1.Desk research
1.1.2.Real-time insights and validation
1.1.3.Forecast model
1.1.4.Assumptions & forecast parameters
1.1.4.1.Assumptions
1.1.4.2.Forecast parameters
CHAPTER 2:EXECUTIVE SUMMARY
2.1.360° summary
2.2.Type trends
2.3.Sample Type trends
2.4.End user trends
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key takeaways
3.2.1.Top investment pockets
3.2.2.Top winning strategies
3.2.2.1.Top winning strategies, by year
3.2.2.2.Top winning strategies, by development
3.2.2.3.Top winning strategies, by company
3.2.3.Top player positioning
3.3.Porter’s five forces analysis
3.4.Market dynamics
3.5.Drivers
3.6.Restraints
3.7.Opportunities
3.8.Technology landscape
3.9.Regulatory landscape
3.10.Market value chain analysis
3.11.Strategic overview
CHAPTER 4:IMPACT OF COVID19 ON DRUG SCREENING LABORATORY SERVICES MARKET
4.1.Introduction
4.2.COVID-19 health assessment
4.3.Impact of COVID-19 on the global economy
4.4.Impact of COVID-19 on global drug screening laboratory services market
4.4.1.Technological impact
4.4.2.Investment scenario
4.5.Drug screening laboratory services market size and forecast, by region, 2020-2028
CHAPTER 5:GLOBAL DRUG SCREENING LABORATORY SERVICES MARKET, BY TYPE
5.1.Overview
5.1.1.Market size and forecast, by type
5.2.Workplace drug testing
5.2.1.Key market trends, growth factors and opportunities
5.2.2.Market size and forecast, by region
5.2.3.Market share analysis, by country
5.3.Clinical toxicological testing
5.3.1.Key market trends, growth factors and opportunities
5.3.2.Market size and forecast, by region
5.3.3.Market share analysis, by country
CHAPTER 6:GLOBAL DRUG SCREENING LABORATORY SERVICES MARKET, BY SAMPLE TYPE
6.1.Overview
6.1.1.Market size and forecast, by sample type
6.2.Urine
6.2.1.Key market trends, growth factors and opportunities
6.2.2.Market size and forecast, by region
6.2.3.Market share analysis, by country
6.3.Oral fluid
6.3.1.Key market trends, growth factors and opportunities
6.3.2.Market size and forecast, by region
6.3.3.Market share analysis, by country
6.4.Hair
6.4.1.Key market trends, growth factors and opportunities
6.4.2.Market size and forecast, by region
6.4.3.Market share analysis, by country
6.5.Others
6.5.1.Key market trends, growth factors and opportunities
6.5.2.Market size and forecast, by region
6.5.3.Market share analysis, by country
CHAPTER 7:GLOBAL DRUG SCREENING LABORATORY SERVICES MARKET BY END USER
7.1.Overview
7.1.1.Market size and forecast, by type
7.2.Retail
7.2.1.Key market trends, growth factors and opportunities
7.2.2.Market size and forecast, by region
7.2.3.Market share analysis, by country
7.3.Oil & Gas
7.3.1.Key market trends, growth factors and opportunities
7.3.2.Market size and forecast, by region
7.3.3.Market share analysis, by country
7.4.Transportation
7.4.1.Key market trends, growth factors and opportunities
7.4.2.Market size and forecast, by region
7.4.3.Market share analysis, by country
7.5.Staffing
7.5.1.Key market trends, growth factors and opportunities
7.5.2.Market size and forecast, by region
7.5.3.Market share analysis, by country
7.6.Government
7.6.1.Key market trends, growth factors and opportunities
7.6.2.Market size and forecast, by region
7.6.3.Market share analysis, by country
7.7.Other workplaces
7.7.1.Key market trends, growth factors and opportunities
7.7.2.Market size and forecast, by region
7.7.3.Market share analysis, by country
CHAPTER 8:GLOBAL DRUG SCREENING LABORATORY SERVICES MARKET, BY REGION
8.1.Overview
8.1.1.Market size and forecast, by region
8.2.North America
8.2.1.Key market trends, growth factors, and opportunities
8.2.2.Market size and forecast, by type
8.2.3.Market size and forecast, by sample type
8.2.4.Market size and forecast, by end-user
8.2.5.Market size and forecast, by country
8.2.6.U.S.
8.2.6.1.Market size and forecast, by type
8.2.6.2.Market size and forecast, by sample type
8.2.6.3.Market size and forecast, by end-user
8.2.7.Canada
8.2.7.1.Market size and forecast, by type
8.2.7.2.Market size and forecast, by sample type
8.2.7.3.Market size and forecast, by end user
8.2.8.Mexico
8.2.8.1.Market size and forecast, by type
8.2.8.2.Market size and forecast, by sample type
8.2.8.3.Market size and forecast, by end user
8.3.Europe
8.3.1.Key market trends, growth factors, and opportunities
8.3.2.Market size and forecast, by type
8.3.3.Market size and forecast, by sample type
8.3.4.Market size and forecast, by end-user
8.3.5.Market size and forecast, by country
8.3.6.Germany
8.3.6.1.Market size and forecast, by type
8.3.6.2.Market size and forecast, by sample type
8.3.6.3.Market size and forecast, by end user
8.3.7.UK
8.3.7.1.Market size and forecast, by type
8.3.7.2.Market size and forecast, by sample type
8.3.7.3.Market size and forecast, by end user
8.3.8.France
8.3.8.1.Market size and forecast, by type
8.3.8.2.Market size and forecast, by sample type
8.3.8.3.Market size and forecast, by end user
8.3.9.Italy
8.3.9.1.Market size and forecast, by type
8.3.9.2.Market size and forecast, by sample type
8.3.9.3.Market size and forecast, by end user
8.3.10.Spain
8.3.10.1.Market size and forecast, by type
8.3.10.2.Market size and forecast, by sample type
8.3.10.3.Market size and forecast, by end user
8.3.11.Rest of Europe
8.3.11.1.Market size and forecast, by type
8.3.11.2.Market size and forecast, by sample type
8.3.11.3.Market size and forecast, by end user
8.4.Asia-Pacific
8.4.1.Key market trends, growth factors, and opportunities
8.4.2.Market size and forecast, by type
8.4.3.Market size and forecast, by sample type
8.4.4.Market size and forecast, by end user
8.4.5.Market size and forecast, by country
8.4.6.China
8.4.6.1.Market size and forecast, by type
8.4.6.2.Market size and forecast, by sample type
8.4.6.3.Market size and forecast, by end user
8.4.7.Japan
8.4.7.1.Market size and forecast, by type
8.4.7.2.Market size and forecast, by sample type
8.4.7.3.Market size and forecast, by end user
8.4.8.Australia
8.4.8.1.Market size and forecast, by type
8.4.8.2.Market size and forecast, by sample type
8.4.8.3.Market size and forecast, by end user
8.4.9.South Korea
8.4.9.1.Market size and forecast, by type
8.4.9.2.Market size and forecast, by sample type
8.4.9.3.Market size and forecast, by end user
8.4.10.India
8.4.10.1.Market size and forecast, by type
8.4.10.2.Market size and forecast, by sample type
8.4.10.3.Market size and forecast, by end user
8.4.11.Rest of Asia-Pacific
8.4.11.1.Market size and forecast, by type
8.4.11.2.Market size and forecast, by sample type
8.4.11.3.Market size and forecast, by end user
8.5.LAMEA
8.5.1.Key market trends, growth factors, and opportunities
8.5.2.Market size and forecast, by type
8.5.3.Market size and forecast, by sample type
8.5.4.Market size and forecast, by end user
8.5.5.Market size and forecast, by country
8.5.6.Latin America
8.5.6.1.Market size and forecast, by type
8.5.6.2.Market size and forecast, by sample type
8.5.6.3.Market size and forecast, by end user
8.5.7.Middle East
8.5.7.1.Market size and forecast, by type
8.5.7.2.Market size and forecast, by sample type
8.5.7.3.Market size and forecast, by end user
8.5.8.Africa
8.5.8.1.Market size and forecast, by type
8.5.8.2.Market size and forecast, by sample type
8.5.8.3.Market size and forecast, by end user
CHAPTER 9:COMPANY PROFILES
9.1.Abbott Laboratories
9.1.1.Company overview
9.1.2.Company snapshot
9.1.3.Operating business segments
9.1.4.Product portfolio
9.1.5.Business performance
9.1.6.Key strategic moves and developments
9.2.Quest Diagnostics
9.2.1.Company overview
9.2.2.Company snapshot
9.2.3.Operating business segments
9.2.4.Product portfolio
9.2.5.Business performance
9.2.6.Key strategic moves and developments
9.3.Clinical Reference Laboratory, Inc
9.3.1.Company overview
9.3.2.Company snapshot
9.3.3.Product portfolio
9.3.4.Key strategic moves and developments
9.4.Laboratory Corporation of America Holdings
9.4.1.Company overview
9.4.2.Company snapshot
9.4.3.Operating business Segments
9.4.4.Product portfolio
9.4.5.Business performance
9.4.6.Key strategic moves and developments
9.5.Cordant Health Solutions
9.5.1.Company overview
9.5.2.Company snapshot
9.5.3.Product portfolio
9.5.4.Key strategic moves and developments
9.6.Psychemedics Corporation
9.6.1.Company overview
9.6.2.Company snapshot
9.6.3.Product portfolio
9.6.4.Business performance
9.6.5.Key strategic moves and developments
9.7.ACM Global Laboratories
9.7.1.Company overview
9.7.2.Company snapshot
9.7.3.Product portfolio
9.7.4.Key strategic moves and development
9.8.Omega Laboratories
9.8.1.Company overview
9.8.2.Company snapshot
9.8.3.Product portfolio
9.8.4.Key strategic moves and developments
9.9.Millennium Health
9.9.1.Company overview
9.9.2.Company snapshot
9.9.3.Product portfolio
9.9.4.Key strategic moves and developments
9.10.Precision Diagnostics
9.10.1.Company overview
9.10.2.Company snapshot
9.10.3.Product portfolio
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/